Conference Coverage

Increasing sepsis survivorship creates new challenges


 

AT CCC47

An upward trend in sepsis survivorship drove increases in sepsis survivors at risk for readmission and returns of these patients to the hospital via the emergency department, results of a retrospective, single-center analysis suggest.

Dr. Mark E. Mikkelson, associate professor of medicine at the Hospital of the University of Pennsylvania. Andrew Bowser/Frontline Medical News

Dr. Mark E. Mikkelson

While 30-day readmission rates declined modestly over the same time period, that decrease was offset by a rise in emergency department treat-and-release visits, explained Dr. Mikkelsen, who coauthored the study.

Over the time period that Dr. Mikkelsen and his colleagues analyzed, the proportion of sepsis hospitalizations more than doubled from 3.9% to 9.4%, while in-hospital mortality rates for sepsis hospitalizations fell from 24.1% to 14.8%. As a result, the proportion of discharged patients at risk for readmission increased from 2.7% to 7.8%, noted Dr. Mikkelsen, associate professor of medicine at the Hospital of the University Of Pennsylvania, Philadelphia.

Pages

Recommended Reading

Ventricular assist devices linked to sepsis
MDedge Infectious Disease
Study: Macrolide treatment lowers risk of failure in pediatric CAP patients
MDedge Infectious Disease
VA study finds high MRSA infection risk among those colonized with the bacterium
MDedge Infectious Disease
Negative nasal swabs reliably predicted no MRSA infection
MDedge Infectious Disease
Wait at least 2 days to replace central venous catheters in patients with candidemia
MDedge Infectious Disease
In-hospital outcomes are better for vaccinated H1N1 patients
MDedge Infectious Disease
VIDEO: Rapid influenza test obviates empiric antivirals
MDedge Infectious Disease
Inpatient antiviral treatment reduces ICU admissions among influenza patients
MDedge Infectious Disease
REPROVE: Ceftazidime-avibactam noninferior to meropenem for nosocomial pneumonia
MDedge Infectious Disease
Combo therapy does not improve outcomes for A. Baumannii
MDedge Infectious Disease